Literature DB >> 23462187

Melphalan continues to rock the myeloma world.

Saad Z Usmani1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23462187     DOI： 10.1016/j.bbmt.2013.02.014

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  2 in total

1.  Risk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myeloma.

Authors:  Saad Z Usmani; Jeffrey Sawyer; Adam Rosenthal; Michele Cottler-Fox; Joshua Epstein; Shmuel Yaccoby; Rachael Sexton; Antje Hoering; Zeba Singh; Christoph J Heuck; Sarah Waheed; Nabeel Chauhan; Donald Johann; Al-Ola Abdallah; Jameel Muzaffar; Nathan Petty; Clyde Bailey; John Crowley; Frits van Rhee; Bart Barlogie
Journal:  Blood       Date:  2013-04-19       Impact factor: 22.113

2.  Multiple Differential Networks Strategy Reveals Carboplatin and Melphalan-Induced Dynamic Module Changes in Retinoblastoma.

Authors:  Cui Chen; Feng-Wei Ma; Cui-Yun Du; Ping Wang
Journal:  Med Sci Monit       Date:  2016-05-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.